Guardant Health, Inc. GH

Set alert

Price alert · GH

All alert types
174.54 USD +3.81 +2.23%

As of Nov 3, 12:47 PM ET

Bid
174.37 × 1
Ask
174.58 × 1
167.31 Day range 178.20
78.60 52-week range 187.22
YTD
+70.88%
1 year
+76.44%
Open
172.96
Prev close
170.73
Mkt cap
23.41B
Vol
668.66K
Avg vol
1.90M
EPS
-3.50
P/E
0.00
Div yield
0.00%
More statistics
Low
167.31
High
178.20
Forward P/E
-450.27
Beta
1.66
Short ratio
6.12
Inst. own
103.19%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
169.71
200-d avg
130.50
1y target
202.24

3M chart

Chart tools
Interval

Events in this range
  • Sep 9, 2026Rating: UBS · Buy → Buy
  • Oct 1, 2026Rating: Guggenheim · Buy → Buy
  • Oct 7, 2026Rating: Barclays · Overweight → Overweight
  • Oct 13, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Oct 23, 2026Rating: Roth Capital · — → Buy
  • Oct 27, 2026Rating: BTIG · Buy → Buy
Signals (26)
NameDateAgo
SMA: BullishNov 3, 20263 hours ago
SMA: BearishNov 2, 20261 day ago
SMA: BullishOct 26, 20261 week ago
MACD: Buy SignalOct 26, 20261 week ago
SMA: BullishOct 23, 20261 week ago
SMA: BearishOct 8, 20263 weeks ago
MACD: Sell SignalOct 6, 20264 weeks ago
MACD: Buy SignalOct 5, 20264 weeks ago
MACD: Sell SignalOct 1, 20261 month ago
MACD: Buy SignalSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BullishSep 9, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishAug 31, 20262 months ago
MACD: Sell SignalAug 28, 20262 months ago
MACD: Buy SignalAug 26, 20262 months ago

Newest 20 of 26.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 202.24 +15.9% upside
Target (low)
105.00
Target (mean)
202.24
Target (high)
240.00
Ratings (0m) 26 25 buy · 0 hold · 1 sell
  • Strong buy4
  • Buy21
  • Hold0
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 26
  • 1 month ago 26
  • 2 months ago 25

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

GH analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.31444-0.39 – -0.22-0.39+19.4%350.64M+32.2%17
Next quarter-0.27901-0.57011 – -0.17-0.50+44.2%369.15M+31.2%17
Current year-1.45-1.81 – -1.18-1.82+20.5%1.36B+38.4%21
Next year-0.37917-1.43 – 0.7236-1.45+73.8%1.84B+35.2%19

Upgrades and downgrades

The latest rating changes

GH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 27, 2026BTIGMaintainedBuyBuy
Oct 23, 2026Roth CapitalInitiated—Buy
Oct 13, 2026Morgan StanleyMaintainedOverweightOverweight
Oct 7, 2026BarclaysMaintainedOverweightOverweight
Oct 1, 2026GuggenheimMaintainedBuyBuy
Sep 9, 2026UBSMaintainedBuyBuy
Sep 8, 2026Rothschild & CoInitiated—Buy
Sep 2, 2026BTIGReiteratedBuyBuy
Aug 4, 2026Piper SandlerMaintainedOverweightOverweight
Aug 4, 2026Stephens & Co.MaintainedOverweightOverweight
Aug 4, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 3, 2026StifelMaintainedBuyBuy
Jul 31, 2026RBC CapitalMaintainedOutperformOutperform
Jul 31, 2026MizuhoMaintainedOutperformOutperform
Jul 31, 2026JP MorganMaintainedOverweightOverweight
Jul 31, 2026TD CowenMaintainedBuyBuy
Jul 31, 2026BarclaysMaintainedOverweightOverweight
Jul 31, 2026BTIGMaintainedBuyBuy
Jul 16, 2026GuggenheimMaintainedBuyBuy
Jul 14, 2026Canaccord GenuityMaintainedBuyBuy
Jul 9, 2026Morgan StanleyMaintainedOverweightOverweight
Jul 8, 2026CitigroupMaintainedBuyBuy
Jul 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Jul 6, 2026B of A SecuritiesMaintainedBuyBuy
Jul 2, 2026BernsteinMaintainedOutperformOutperform
Jul 1, 2026BTIGMaintainedBuyBuy
Jun 29, 2026GuggenheimMaintainedBuyBuy
Jun 24, 2026BarclaysMaintainedOverweightOverweight
Jun 11, 2026RBC CapitalInitiated—Outperform
Jun 8, 2026MizuhoMaintainedOutperformOutperform